Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potassium channelopathies

M C Sanguinetti1, P S Spector

  • 1Department of Medicine, University of Utah, Salt Lake City 84112, USA. mike.sanguinetti@genetics.utah.edu

Neuropharmacology
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ablation strategies reflect evolving concepts of atrial fibrillation mechanisms.

Journal of electrocardiology·2002
Same author

The S4-S5 linker couples voltage sensing and activation of pacemaker channels.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Long-QT syndrome-associated missense mutations in the pore helix of the HERG potassium channel.

Circulation·2001
Same author

Open channel block of HERG K(+) channels by vesnarinone.

Molecular pharmacology·2001
Same author

Short- and long-term effects of amiodarone on the two components of cardiac delayed rectifier K(+) current.

Circulation·2001
Same author

Molecular and cellular mechanisms of cardiac arrhythmias.

Cell·2001
Same journal

Thyrotropin-releasing hormone and dopaminergic systems interact in the ventral tegmental area to regulate food intake in rats.

Neuropharmacology·2026
Same journal

TRPC5 as a modulator of TRPV1 signalling in pathological pain states.

Neuropharmacology·2026
Same journal

Loss of mGlu<sub>5</sub> receptors from PV inhibitory neurons attenuates sex differences in ethanol and sucrose seeking.

Neuropharmacology·2026
Same journal

PM289, a synthetic CB2 in vitro receptor agonist, modulates morphine-induced antinociceptive effect and withdrawal syndrome in an animal model of osteoarthritic pain.

Neuropharmacology·2026
Same journal

Purinergic-cytokine signaling as a regulatory axis in neuroimmune development.

Neuropharmacology·2026
Same journal

Acupuncture improves depressive symptoms and prefrontal cortical function in mild to moderate depressive disorder: A randomized sham-controlled trial and fNIRS study.

Neuropharmacology·2026
See all related articles

Potassium channels are diverse and crucial for cell function. Mutations in these channels cause human diseases like long QT syndrome, offering targets for new therapies.

Area of Science:

  • Molecular biology
  • Neuroscience
  • Genetics

Background:

  • Potassium channels exhibit extensive molecular diversity, exceeding other ion channel types due to their ancient origins.
  • These channels play vital roles in modulating electrical activity in various cell types, including neurons, myocytes, and endocrine cells.
  • Differential expression of potassium channels dictates specific cellular electrical responses.

Purpose of the Study:

  • To review recent genetic and physiological studies on congenital disorders linked to potassium channel gene mutations.
  • To highlight the connection between potassium channel dysfunction and specific human diseases.

Main Methods:

  • Review of recent genetic studies.
  • Review of recent physiological studies.

Related Experiment Videos

  • Analysis of congenital disorders associated with potassium channel gene mutations.

    • Main Results:

    • Identified human disorders including episodic ataxia with myokymia, long QT syndrome, and Bartter's syndrome.
    • Identified a related disorder in mice: weaver ataxia.
    • Established the link between specific gene mutations and these channelopathies.

    Conclusions:

    • Understanding the molecular basis of these potassium channel disorders is essential.
    • This knowledge can guide the development of targeted pharmacological treatments for these conditions.